PMV Pharmaceuticals Inc Stock
PMV Pharmaceuticals Inc Stock price
Key metrics
| Market capitalization | $77.62m |
| Enterprise Value | $-92.77m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | 1.95 |
| P/B ratio (TTM) P/B ratio | 0.39 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-79.18m |
| Free Cash Flow (TTM) Free Cash Flow | $-47.50m |
| Cash position | $183.66m |
Is PMV Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
PMV Pharmaceuticals Inc Stock Analysis
Analyst Opinions
6 Analysts have issued a PMV Pharmaceuticals Inc forecast:
Analyst Opinions
6 Analysts have issued a PMV Pharmaceuticals Inc forecast:
Financial data from PMV Pharmaceuticals Inc
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -1.46 -1.46 |
51%
51%
|
|
| EBITDA | -78 -78 |
5%
5%
|
EBIT (Operating Income) EBIT | -79 -79 |
4%
4%
|
| Net Profit | -51 -51 |
29%
29%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about PMV Pharmaceuticals Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
PMV Pharmaceuticals, Inc. engages in the development of p53 targeted small molecule drugs for the treatment of cancer. It combines unique biological understanding with pharmaceutical development focus. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in 2013 and is headquartered in New Jersey, NY.
| Head office | United States |
| CEO | David Mack |
| Employees | 63 |
| Founded | 2013 |
| Website | www.pmvpharma.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
